CARA MESSIER: Open Payments
NPI 1518653096 · APOPKA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 7 payments from 6 companies in 2025. Trend: 2023 $247 · 2024 $398 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 2 | $152 |
| Incyte Corporation | 1 | $132 |
| Gilead Sciences, Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $112 |
| Merck Sharp & Dohme LLC | 1 | $112 |
| CATALYST PHARMACEUTICALS, INC. | 1 | $91 |
Products named: Orserdu, Jakafi, Trodelvy, KEYTRUDA, FIRDAPSE.
Industry payments across FL — which companies pay providers there.
